Robotic-assisted laparoscopic catheterizable bladder augment: a novel approach to treat recurrent XXXX following radical prostatectomy.

@entity1 @entity427 @entity1494 @entity1011
INTRODUCTION: @entity1494 ( @entity1494 ) are an uncommon complication following radical prostatectomy. Occasionally, BNCs can be refractory to endoscopic approaches. We describe the effectiveness of a novel robotic-assisted laparoscopic catheterizable bladder augment in treating recalcitrant BNCs. MATERIALS AND METHODS: @entity1 undergoing robotic-assisted radical prostatectomy (RALP) between 2004-2014 who developed a postoperative @entity1494 were identified. We documented our experience with robotic-assisted laparoscopic catheterizable bladder augment for recalcitrant BNCs. Total operative time, robotic time, estimated surgical blood, length of hospital stay, serum @entity1011 , complications, and postoperative course/upper tract imaging were recorded. RESULTS: Thirty-six of 2002 RALP @entity1 (1.8%) experienced a post-surgical @entity1494 at 182 days post-surgery. Twenty-two (61.1%) underwent a single dilation and/or transurethral incision. Eleven (30.6%) required = 1 procedure. Three @entity1 (8.3%) had recalcitrant BNCs. One @entity1 with normal bladder capacity elected open urethroplasty. The remaining two had @entity1494 , detrusor over-activity and failed multiple incisions and self-catheterization. In one @entity1 , the stricture was complete. The other @entity1 experienced urethral leakage requiring bladder neck closure. In both @entity1 , a robotic approach, utilizing an ileal-cecal segment as a catheterizable augment, was performed. At 16 and 89 months follow up, both are continent, with stable renal function and normal upper tracts. CONCLUSION: Robotic-assisted laparoscopic catheterizable bladder augment is a viable treatment for recurrent BNCs. This approach may be particularly well suited for @entity1 with concurrent @entity427 or decreased bladder capacity.
